Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
about
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacementVenous thromboembolic diseaseTransitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopeniaLepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3A comparison of lepirudin and argatroban outcomesAtomic description of the immune complex involved in heparin-induced thrombocytopeniaArgatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia.New developments in diagnosis and treatment of heparin-induced thrombocytopenia.Alternative parenteral anticoagulation with argatroban, a direct thrombin inhibitor.Diagnosis and management of heparin-induced thrombocytopenia.Coronary artery stent thrombosis associated with heparin-induced thrombocytopenia: case report and review of the literature.Direct thrombin inhibitors: pharmacology and clinical relevance.Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications.Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia from venous thromboembolism treatment.Argatroban, a direct thrombin inhibitor for heparin-induced thrombocytopaenia: present and future perspectives.Treatment of heparin-induced thrombocytopenia in cardiovascular patients.Argatroban for suspected heparin-induced thrombocytopenia: contemporary experience at a large teaching hospital.Evaluation of bivalirudin treatment for heparin-induced thrombocytopenia in critically ill patients with hepatic and/or renal dysfunction.Argatroban dosing of patients with heparin-induced thrombocytopenia and an elevated aPTT due to antiphospholipid antibody syndrome.Bilateral lower extremity gangrene requiring amputation associated with heparin-induced thrombocytopenia--a case report.Anticoagulation strategies for treatment of ischemic stroke and antiphospholipid syndrome: case report and review of the literature.Heparin-induced thrombocytopenia in patients administered heparin solely for hemodialysis.Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia: treatment options and special considerations.Testing for heparin-induced thrombocytopenia: are we there yet?Bilateral lower extremity gangrene requiring amputation associated with heparin-induced thrombocytopenia: a case report.Argatroban anticoagulation in obese versus nonobese patients: implications for treating heparin-induced thrombocytopenia.Argatroban therapy in patients with coronary artery disease and heparin-induced thrombocytopenia.Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients.Safety, efficacy, and dosing requirements of bivalirudin in patients with heparin-induced thrombocytopenia.Current concepts review: heparin-induced thrombocytopenia.Review: recent advances in argatroban-warfarin transition in patients with heparin-induced thrombocytopenia.Weight-based argatroban dosing nomogram for treatment of heparin-induced thrombocytopenia.Evaluation of a clinical scoring scale to direct early appropriate therapy in heparin-induced thrombocytopenia.Argatroban dosage requirements and outcomes in intensive care versus non-intensive care patients.The direct thrombin inhibitor argatroban: a review of its use in patients with and without HIT.Heparin-induced thrombocytopenia: overview and treatment.Update on the clinical applications of argatroban.
P2860
Q24235993-2D9339EC-BACB-400B-83DA-7250040A414DQ24631121-EB4FF2FB-5507-4848-8C15-6EA6126EE6D9Q28261518-0BDD824E-1C68-461C-A081-F48A1F4DB7A6Q28278419-D4B25E51-D010-4A47-8842-4B8E16A7CF04Q28278668-9B619A2A-9EBE-47B3-9700-EF92426AB11AQ30665349-FB1D21F7-170B-4E45-8150-2EEF23FAE0B8Q33364404-40DA8BE1-F31F-46CE-803D-FF6914DA8292Q33364828-E3C10F3D-7657-4BC7-9558-FF1410D064E4Q33365108-2B0247BC-09C5-40BA-8E4C-A9AADCDF0F14Q33365985-BE5538C0-0D28-4073-A2B1-9A7CA22F640EQ33366197-FE362D54-B09C-4540-9FC8-916849FE3BE3Q33366516-5ABE2C8A-B741-4A4F-A2EA-4B47C7A97732Q33368191-E94AE29E-4FCA-4F2E-8BD3-20968AAF8A95Q33369316-1CA7590F-56DA-43F9-A069-FF6F92D587C8Q33369330-9746C087-26A0-4A19-BA86-7C31CA1B8760Q33369355-2460935D-D843-4F75-9FA3-B482D6CD774BQ33369690-0A8126AD-AC8B-47E6-B497-E7FBB8F49AF7Q33370137-B631ED9C-BB41-4CA7-8293-CAC96DB33246Q33370566-24CDA8A0-A5B8-4DDA-B85F-6A8FDE60EE97Q33370636-79180502-06B7-4E72-84B2-7CA9207521F4Q33370696-FC518FE5-7D1B-45D4-9E0E-17B0722723BFQ33370778-19FFFEBF-7825-467E-B872-B4F2C75899FBQ33372751-32BB5EE0-E0F1-4442-889C-640696A94CD9Q33373025-E7F11775-E484-47AA-811E-6778DA0CCAA0Q33373700-BD57D529-BE93-434A-9FEF-5B405CEB9E02Q33374658-8E05CABC-A52D-4915-ABF5-C98EE0B2DB5FQ33374916-19623B7F-9EFC-4CE2-A135-652D166AE7B6Q33375221-7FF6208C-994D-4F4B-83BF-ACA8AC51C9A3Q33375376-26839531-99C1-40AB-8B9E-D4B32EEB7D7FQ33376409-BE69E4EB-8E3E-48FF-86CD-C6F8D7437535Q33376889-6C1AFF11-A103-46E0-B887-BA1EE7AC9636Q33380931-CF33D119-093E-4072-931E-FA9F7897CA89Q33382108-5C23033E-FD5C-4BDD-91BA-65C54F0366E6Q33382275-FECC3A6D-BE55-4AB4-BA12-EA612997FAE3Q33382677-610D857C-EBF6-4B4C-BF9D-38BD6232D44EQ33385898-207E4E5D-5F6A-4324-B310-A3EFF812630DQ33385916-52B68A3E-52F6-48EE-976F-081BF31CBD06Q33385970-6A884C0E-1114-4EF9-98BB-9AC71987798CQ33386197-023940CE-05F2-48C2-BA16-2B4EB4B3A581Q33386502-0C655D9F-5286-4C0A-9654-B477C2CC58FD
P2860
Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
@ast
Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
@en
type
label
Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
@ast
Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
@en
prefLabel
Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
@ast
Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
@en
P2093
P1476
Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
@en
P2093
Argatroban-915 Investigators
Bruce E Lewis
Diane E Wallis
John G Kelton
Marcie J Hursting
P304
P356
10.1001/ARCHINTE.163.15.1849
P407
P577
2003-08-01T00:00:00Z